Dipeptidyl peptidase-4 enzyme inhibition and its impacts on hepatic preneoplasia: a new avenue for liver cancer management
These findings shed the light on the role of DPP-inhibitors in the future of cancer therapy and management.
Authors
- Ayman E. El-Sahar (ORCID: https://orcid.org/0000-0002-7597-2352)
- Hebatollah E. Eitah (ORCID: https://orcid.org/0000-0002-6936-5150)
- Khaled Mahmoud (ORCID: https://orcid.org/0000-0002-1364-4951)
- Hanan Naeim Attia (ORCID: https://orcid.org/0000-0003-2417-9693)
- Yousreya A. Maklad (ORCID: https://orcid.org/0000-0002-5031-6391)
- Rabab H. Sayed
- Amal A. Abdulbaqi
- Amani Alhejely
- Amina A. Gamal el Din
Institutions
- Cairo University (EG)
- National Research Centre (EG)
- Jazan University (SA)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-07-25
- DOI
- https://doi.org/10.3389/fphar.2025.1559303
- Citations
- 2
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- National Research Centre
- Jazan University